雲頂香港(00678.HK)向德國尋求頒令公司提取8,800萬美元融資
雲頂香港(00678.HK)公布,向德國施威林地區法院尋求頒令允許公司向取梅前州提取8,800萬美元備用融資,該將訂於本月11日聆訊。
於2021年12月30日德國時間,梅前州指其仍同意提供備用融資,惟須履行若干額外先決條件,包括德國聯邦政府與公司就向公司附屬MVWH 提供過渡貸款的若干條款訂立進一步協議,為建造「Global One」船舶的持續成本提供資金。梅前州指該解決方案乃其優先考慮的。
公司表示,與MVWH同樣致力於達成梅前州新提議的經談判得出的解決方案,然而公司亦將繼續尋求強制執行其於備用融資協議項下的合約權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.